The latest

News

BrightEdge's Farnaz Bakshi (center) presents Golden Ticket to Brad Niles, CEO of ARIZ (third from left) along with the BrightEdge and Bakar Labs teams
, , ,

ARIZ and Catena Awarded Golden Tickets to Bakar Labs, Sponsored by ACS BrightEdge Fund

With the Golden Tickets, ARIZ and Catena each win one year of free office and lab space at Bakar Labs and access to BrightEdge’s robust network of resources to develop their cancer therapies. They will be able to access Berkeley campus resources, connect with Bakar Labs' business affiliates, and network with more than 30 fellow tenant companies. The combination of support from Bakar Labs and BrightEdge will, most importantly, allow ARIZ and Catena to bring their technology to patients sooner.

Latest news10

A group of people including Tandis Vazin, incoming CEO of Ciznor

Ciznor, Targeting ALS and FTD with Gene Therapy, Wins QB3 Defeating Dementia Award

“The session provided a great platform to present our company and technology to venture and potential industry partners, said Tandis Vazin, PhD, corporate advisor and incoming Ciznor CEO, who presented on behalf of the company. “This award will be instrumental to our new company as it will help us with our initial legal needs and intellectual property strategy.” Read post
BridgeBio logo

BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub

“Partnering with UC Berkeley and QB3 to launch Bakar Labs is a natural extension of our mission to discover, create, test, and deliver transformative medicines to as many patients as possible. Through this collaboration, we aim to strengthen the Bay Area biotech ecosystem and potentially unlock new therapies for patients with unmet needs,” said BridgeBio founder and CEO Neil Kumar, Ph.D. Read post
Josh Yang of Glyphic Bio in their lab at Bakar Labs

How Berkeley Is Leaning in to the Biotech Boom

"Nowadays, they meet in person at the Bakar BioEnginuity Hub, the recently completed lab and office space that is emblematic of UC Berkeley’s efforts to support bioscience startups. It’s part of a web of startup activity on campus that’s so vast, the university created a website to help people navigate it." Read post
Large group of people mingling outside BBH

Berkeley’s Bakar BioEnginuity Hub Opens Its Doors

“We are going to be an incredible model for the country on how to translate technologies to benefit society. Our tenant companies are solving important challenges in medicine and the environment, at the same time as creating high-value jobs,” said BBH Director David Schaffer. “In addition, we at BBH and QB3 are launching undergraduate and graduate training programs with Bakar Labs companies to help train the future workforce of California.” Read post
Decorative graphic with wording "Golden Ticket Competition"

Bakar Labs and the Cystic Fibrosis Foundation Support Entrepreneurs to Develop New Genetic Therapies for CF

Up to 3 selected companies will win "Golden Tickets" for lab space at Bakar Labs, and access to the extensive resources of the CF Foundation, including scientific experts and advice, lab/research tools and techniques, an extensive patient registry, clinical trial design support, and a Therapeutics Development Network of over 90 clinical trial sites in the US. Read post